__NOTOC__ Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., , was a United States Supreme Court case in which the court held that the necessary inducement element of a patent infringement claim must be clear to the relevant audience and affirmative.Syllabus of .

References

External links